Überlebensvorteil bei ATTR-CM

CardioVasc 2026

View at publisher
Authors: Günter Springer
DOI: 10.1007/s15027-026-3968-5
Cited by: 0

Fields of Study & Subjects

Amyloidosis: Diagnosis Treatment Outcomes Heart Failure Treatment and Management Cardiac electrophysiology and arrhythmias

Publication details

Journal / source
CardioVasc
Volume
26
Issue
1
Pages
64–64
Publication date
1 February 2026
Language
DE